As of 20 Nov 2026, SuperMush has raised $3M across 1 verified round on record; latest: $3 million Series A led by NDude Labs, announced 6 Oct 2026.
SuperMush sells functional mushroom-based gummies designed for daily health and performance.
supermush.comUSHealthtechFounded 2022
15 sources · checked 4 times, last 42d ago
The source identifies SuperMush as US-based but does not state a headquarters city.
Published by hand (entrepreneur.economictimes.indiatimes.com): "SuperMush has raised $3 million in a series A round led by NDude Labs.": feed audit 2026-10-14: SuperMush (supermush.com, functional gummies) is the company the release names; the same round was published under its investor NDude Labs
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series A | $3M | 2026-10-06 | NDude Labs | No recent discussion |
15 sources · checked 4 times, last 42d ago [ VERIFIED · CORRECTED ] read against 1 of 15 sources
The source identifies SuperMush as US-based but does not state a headquarters city. Published by hand (entrepreneur.economictimes.indiatimes.com): "SuperMush has raised $3 million in a series A round led by NDude Labs.": feed audit 2026-10-14: SuperMush (supermush.com, functional gummies) is the company the release names; the same round was published under its investor NDude Labs | ||||
SuperMush makes science-backed functional gummies and other supplements for people who want daily support for energy, focus, sleep, passion, and performance.
SuperMush is betting that nootropics, adaptogens, and functional mushrooms can make daily wellness more portable, tasty, and appealing to Gen Z/Y than traditional powders and tinctures, while addressing the fatigue and mental-wellness concerns described in its materials. The $3 million Series A is intended to expand products and formulations and strengthen the team and infrastructure as the brand grows to more than 2,000 US stores, including more than 1,000 Target locations, alongside its website and Amazon sales.
Checked against 10 sources on Oct 6
Also named as backers in company research: Vibrant VC, Humans VC, Mystic VC, Jarret Christie, Ba Minuzzi, Akash Nigam, Jody Levy, Gerard Adams, Julie Smolyansky, Tara Tersigni, Dr. Christian Gonzalez, Devon Levesque, Steven Vigilante, Ryan Lewendon, Andrew Merinoff, Jess Holtz, Braxton Berrios, Connor Saeli, Jeffrey Perlman, Gunnar Lovelace, Jordan Brown, Brendan Brazier, Auston Matthews, Max Lugavere, Marc Randolph, Anthony Gustin, Oliver Trevena, Adrien Grenier